Canadá - inglês - Health Canada

glaxosmithkline inc - salbutamol (salbutamol sulfate) - solution - 1mg - salbutamol (salbutamol sulfate) 1mg - selective beta 2-adrenergic agonists

Canadá - inglês - Health Canada

glaxo canada inc - salbutamol (salbutamol sulfate) - solution - 5mg - salbutamol (salbutamol sulfate) 5mg - selective beta 2-adrenergic agonists

Canadá - inglês - Health Canada

glaxosmithkline inc - salbutamol (salbutamol sulfate) - powder - 200mcg - salbutamol (salbutamol sulfate) 200mcg - selective beta 2-adrenergic agonists

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 264 microgram - insufflation - excipient ingredients: lactose monohydrate - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm. ventolin rotacaps are indicated for the above conditions in those patients unable to use a pressurised aerosol bronchodilator satisfactorily. patients most likely to benefit from the use of rotacaps are: 1) children from 3 to 6 years of age who are too young to operate a metered aerosol. 2) patients who have difficulty synchronising deep inhalation with actuation of a metered aerosol. 3) patients who are sensitive to freon propellants.

Cingapura - inglês - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - budesonide; formoterol fumarate dihydrate; glycopyrronium bromide eqv glycopyrronium - aerosol, metered - budesonide 160 μg/actuation; formoterol fumarate dihydrate 5.0 μg/actuation; glycopyrronium bromide eqv glycopyrronium 7.2 μg/actuation

Canadá - inglês - Health Canada

glaxosmithkline inc - salbutamol - metered-dose aerosol - 100mcg - salbutamol 100mcg - selective beta 2-adrenergic agonists

Israel - inglês - Ministry of Health

glaxo smith kline (israel) ltd - salbutamol as sulfate - tablets - salbutamol as sulfate 2 mg - salbutamol - salbutamol - relief of bronchospasm in bronchial asthma of all types, chronic bronchitis, emphysema.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 2.4 mg/ml (equivalent: salbutamol, qty 2 mg/ml) - inhalation - excipient ingredients: sodium chloride; sulfuric acid; water for injections - indications as at 1st february 1999: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 1.2 mg/ml (equivalent: salbutamol, qty 1 mg/ml) - inhalation - excipient ingredients: sodium chloride; water for injections; sulfuric acid - indications as at 1st february 1999: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.

Canadá - inglês - Health Canada

bausch health, canada inc. - salbutamol (salbutamol sulfate) - metered-dose aerosol - 100mcg - salbutamol (salbutamol sulfate) 100mcg - selective beta 2-adrenergic agonists